- Home
- AGIO vs SPB Comparison
AGIO vs SPB Comparison
Compare AGIO & SPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGIO | SPB |
|---|---|---|
| Founded | 2007 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | AGIO | SPB |
|---|---|---|
| Price | $26.97 | $61.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $32.13 | ★ $83.50 |
| AVG Volume (30 Days) | ★ 2.7M | 325.6K |
| Earning Date | 10-30-2025 | 11-13-2025 |
| Dividend Yield | N/A | ★ 3.06% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.86 |
| Revenue | $44,791,000.00 | ★ $2,809,000,000.00 |
| Revenue This Year | $28.75 | $1.64 |
| Revenue Next Year | $139.45 | $1.47 |
| P/E Ratio | ★ N/A | $15.90 |
| Revenue Growth | ★ 36.26 | N/A |
| 52 Week Low | $22.24 | $49.99 |
| 52 Week High | $46.00 | $92.64 |
Technical Indicators
Market Signals| Indicator | AGIO | SPB |
|---|---|---|
| Relative Strength Index (RSI) | 35.66 | 61.67 |
| Support Level | $26.80 | $55.93 |
| Resistance Level | $28.61 | $63.12 |
| Average True Range (ATR) | 1.15 | 1.60 |
| MACD | 0.28 | 0.32 |
| Stochastic Oscillator | 16.59 | 71.22 |
Price Performance
Historical ComparisonAbout AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.
About SPB Spectrum Brands Holdings Inc.
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.